/newsroom/taxonomy/term/1959/all en /newsroom/channels/news/experts-fda-approves-much-debated-alzheimers-drug-panned-experts-331414 <p>U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease. The Food and Drug Administration (FDA) said it granted approval to the drug from Biogen based on results that seemed “reasonably likely” to benefit Alzheimer's patients. (<a href="https://www.ctvnews.ca/health/fda-approves-much-debated-alzheimer-s-drug-panned-by-experts-1.5459470" target="_blank">CTV News</a>)</p> Tue, 08 Jun 2021 20:48:35 +0000 frederique.mazerolle@mcgill.ca 269362 at /newsroom /newsroom/channels/news/expert-opinion-covid-19-vaccine-rollout-unlikely-fall-2021-325084 <p>Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published recently in the <a href="https://link.springer.com/article/10.1007/s11606-020-06244-9"><i>Journal of General Internal Medicine</i></a>, a ���۲�ݮ��Ƶ-led team published the results of a recent survey of 28 experts working in vaccinology.</p> Thu, 01 Oct 2020 15:30:00 +0000 katherine.gombay@mcgill.ca 241817 at /newsroom /newsroom/channels/news/ctv-news-hundreds-canadians-willing-be-infected-coronavirus-speed-vaccine-research-322221 <p>Thousands of healthy volunteers, including hundreds of Canadians, have offered to try getting injected with a potential vaccine and then purposely becoming infected with COVID-19 to test if the vaccine works. <strong>Jonathan Kimmelman</strong>, a professor of biomedical ethics at ���۲�ݮ��Ƶ University, expressed concerns about the risks.</p> Tue, 19 May 2020 17:28:29 +0000 amelia.souffrant@mail.mcgill.ca 211699 at /newsroom /newsroom/channels/news/national-post-mom-fears-losing-access-experimental-drug-helped-daughter-after-study-ends-286237 <p>Jonathan Kimmelman, director of biomedical ethics at ���۲�ݮ��Ƶ University, agreed companies have some obligation to continue to provide care for patients who take part in studies to test experimental products. “Any time a patient participates in a trial, they’re volunteering their body to advance science,” he said from Montreal. “And if it’s a trial being run by a pharmaceutical company, they’re volunteering their bodies to advance the goals of the pharmaceutical company, whether that’s a big pharmaceutical company or a small one.</p> Tue, 27 Mar 2018 17:29:38 +0000 nathan.menezes@mail.mcgill.ca 35538 at /newsroom /newsroom/channels/news/bloomberg-scientists-dont-fear-new-crispr-snag-284111 <p>I talked this over with ���۲�ݮ��Ƶ University medical ethicist Jonathan Kimmelman, who specializes in the risks of medical experiments and has written a book about them centered on the Jesse Gelsinger case. Of course, he says, money isn’t the only thing that might prevent medical researchers from being perfectly objective -- there’s the desire to be heroes, to beat rivals, and to help patients. A bigger concern is the fact that whatever is driving scientists, they can have blind spots just like everyone else.</p> Wed, 24 Jan 2018 00:25:01 +0000 laurie.devine@mcgill.ca 32890 at /newsroom /newsroom/channels/news/proliferating-drug-trials-pose-pitfalls-doctors-and-patients-269946 <p> Thu, 31 Aug 2017 15:00:52 +0000 cynthia.lee@mcgill.ca 32226 at /newsroom /newsroom/channels/news/cancer-researchers-overestimate-reproducibility-preclinical-studies-268784 <p>Cancer scientists overestimate the extent to which high-profile preclinical studies can be successfully replicated, new research from ���۲�ݮ��Ƶ University suggests.</p> Wed, 28 Jun 2017 20:40:17 +0000 justin.dupuis@mcgill.ca 32027 at /newsroom /newsroom/jonathan-kimmelman Tue, 26 Feb 2019 16:59:44 +0000 priya.pajel@mail.mcgill.ca 24543 at /newsroom /newsroom/channels/news/cancer-research-plagued-poor-study-design-256090 <p>Badly designed studies may lead to the efficacy of drugs being overestimated and money being wasted on trials that prove fruitless, according to a new study from ���۲�ݮ��Ƶ University in Canada.</p> <p> Wed, 14 Oct 2015 18:41:04 +0000 melody.enguix@mcgill.ca 24536 at /newsroom